FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003299841> ?p ?o ?g. }

• W2003299841 endingPage "5264" @default.
• W2003299841 startingPage "5257" @default.
• W2003299841 abstract "Synthesis of (R)-(−)- and (S)-(+)-synadenol (1a and 2a, 95−96% ee) is described. Racemic synadenol (1a + 2a) was deaminated with adenosine deaminase to give (R)-(−)-synadenol (1a) and (S)-(+)-hypoxanthine derivative 5. Acetylation of the latter compound gave acetate 6. Reaction with N,N-dimethylchloromethyleneammonium chloride led to 6-chloropurine derivative 7. Ammonolysis furnished (S)-(+)-synadenol (2a). Absolute configuration of 1a was established by two methods: (i) synthesis from (R)-methylenecyclopropanecarboxylic acid (8) and (ii) X-ray diffraction of a single crystal of (−)-synadenol hydrochloride. Racemic methylenecyclopropanecarboxylic acid (10) was resolved by a modification of the described procedure. The R-enantiomer 8 was converted to ethyl ester 13 which was brominated to give vicinal dibromides 14. Reduction with diisobutylaluminum hydride then furnished alcohol 15 which was acetylated to the corresponding acetate 16. Alkylation−elimination procedure of adenine with 16 yielded acetates 17 and 18. Deprotection with ammonia afforded a mixture of Z- and E-isomers 1a and 19 of the R-configuration. Comparison with products 1a and 2a by chiral HPLC established the R-configuration of (−)-synadenol (1a). These results were confirmed by X-ray diffraction of a single crystal of (−)-synadenol hydrochloride. The latter forms a pseudosymmetric dimer with adenine−adenine base pairing in the lattice with the nucleobase in an anti-like conformation. Enantiomers 1a and 2a exhibit varied enantioselectivity toward different viruses. Both enantiomers are equipotent against human cytomegalovirus (HCMV) and varicella zoster virus (VZV). The S-enantiomer 2a is somewhat more effective than R-enantiomer 1a in herpes simplex virus 1 and 2 (HSV-1 and HSV-2) assays. By contrast, enantioselectivity of antiviral effect is reversed in Epstein-Barr virus (EBV) and human immunodeficiency virus type 1 (HIV-1) assays where the R-enantiomer 1a is preferred. In these assays, the S-enantiomer 2a is less effective (EBV) or devoid of activity (HIV-1)." @default.
• W2003299841 created "2016-06-24" @default.
• W2003299841 creator A5000085395 @default.
• W2003299841 creator A5000210067 @default.
• W2003299841 creator A5004932382 @default.
• W2003299841 creator A5006348104 @default.
• W2003299841 creator A5031471721 @default.
• W2003299841 creator A5031779138 @default.
• W2003299841 creator A5034322715 @default.
• W2003299841 creator A5047478211 @default.
• W2003299841 creator A5052420009 @default.
• W2003299841 creator A5076281231 @default.
• W2003299841 creator A5089369644 @default.
• W2003299841 creator A5090566144 @default.
• W2003299841 creator A5091601865 @default.
• W2003299841 date "1998-12-01" @default.
• W2003299841 modified "2023-10-15" @default.
• W2003299841 title "(R)-(−)- and (S)-(+)-Synadenol: Synthesis, Absolute Configuration, and Enantioselectivity of Antiviral Effect✗" @default.
• W2003299841 cites W1563954963 @default.
• W2003299841 cites W1620284542 @default.
• W2003299841 cites W1968008788 @default.
• W2003299841 cites W1999580476 @default.
• W2003299841 cites W2014483516 @default.
• W2003299841 cites W2015727269 @default.
• W2003299841 cites W2027367379 @default.
• W2003299841 cites W2128179591 @default.
• W2003299841 cites W2488228502 @default.
• W2003299841 cites W2952331848 @default.
• W2003299841 doi "https://doi.org/10.1021/jm980323u" @default.
• W2003299841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9857093" @default.
• W2003299841 hasPublicationYear "1998" @default.
• W2003299841 type Work @default.
• W2003299841 sameAs 2003299841 @default.
• W2003299841 citedByCount "36" @default.
• W2003299841 countsByYear W20032998412012 @default.
• W2003299841 countsByYear W20032998412013 @default.
• W2003299841 countsByYear W20032998412014 @default.
• W2003299841 countsByYear W20032998412018 @default.
• W2003299841 countsByYear W20032998412021 @default.
• W2003299841 crossrefType "journal-article" @default.
• W2003299841 hasAuthorship W2003299841A5000085395 @default.
• W2003299841 hasAuthorship W2003299841A5000210067 @default.
• W2003299841 hasAuthorship W2003299841A5004932382 @default.
• W2003299841 hasAuthorship W2003299841A5006348104 @default.
• W2003299841 hasAuthorship W2003299841A5031471721 @default.
• W2003299841 hasAuthorship W2003299841A5031779138 @default.
• W2003299841 hasAuthorship W2003299841A5034322715 @default.
• W2003299841 hasAuthorship W2003299841A5047478211 @default.
• W2003299841 hasAuthorship W2003299841A5052420009 @default.
• W2003299841 hasAuthorship W2003299841A5076281231 @default.
• W2003299841 hasAuthorship W2003299841A5089369644 @default.
• W2003299841 hasAuthorship W2003299841A5090566144 @default.
• W2003299841 hasAuthorship W2003299841A5091601865 @default.
• W2003299841 hasConcept C104317684 @default.
• W2003299841 hasConcept C114373084 @default.
• W2003299841 hasConcept C161790260 @default.
• W2003299841 hasConcept C164361826 @default.
• W2003299841 hasConcept C178790620 @default.
• W2003299841 hasConcept C181199279 @default.
• W2003299841 hasConcept C185592680 @default.
• W2003299841 hasConcept C202751555 @default.
• W2003299841 hasConcept C25170562 @default.
• W2003299841 hasConcept C2776460385 @default.
• W2003299841 hasConcept C2776844798 @default.
• W2003299841 hasConcept C2779546866 @default.
• W2003299841 hasConcept C2781116151 @default.
• W2003299841 hasConcept C486523 @default.
• W2003299841 hasConcept C55493867 @default.
• W2003299841 hasConcept C67705224 @default.
• W2003299841 hasConcept C71240020 @default.
• W2003299841 hasConceptScore W2003299841C104317684 @default.
• W2003299841 hasConceptScore W2003299841C114373084 @default.
• W2003299841 hasConceptScore W2003299841C161790260 @default.
• W2003299841 hasConceptScore W2003299841C164361826 @default.
• W2003299841 hasConceptScore W2003299841C178790620 @default.
• W2003299841 hasConceptScore W2003299841C181199279 @default.
• W2003299841 hasConceptScore W2003299841C185592680 @default.
• W2003299841 hasConceptScore W2003299841C202751555 @default.
• W2003299841 hasConceptScore W2003299841C25170562 @default.
• W2003299841 hasConceptScore W2003299841C2776460385 @default.
• W2003299841 hasConceptScore W2003299841C2776844798 @default.
• W2003299841 hasConceptScore W2003299841C2779546866 @default.
• W2003299841 hasConceptScore W2003299841C2781116151 @default.
• W2003299841 hasConceptScore W2003299841C486523 @default.
• W2003299841 hasConceptScore W2003299841C55493867 @default.
• W2003299841 hasConceptScore W2003299841C67705224 @default.
• W2003299841 hasConceptScore W2003299841C71240020 @default.
• W2003299841 hasIssue "26" @default.
• W2003299841 hasLocation W20032998411 @default.
• W2003299841 hasLocation W20032998412 @default.
• W2003299841 hasOpenAccess W2003299841 @default.
• W2003299841 hasPrimaryLocation W20032998411 @default.
• W2003299841 hasRelatedWork W113026154 @default.
• W2003299841 hasRelatedWork W1964585240 @default.
• W2003299841 hasRelatedWork W1966741291 @default.
• W2003299841 hasRelatedWork W1971746110 @default.
• W2003299841 hasRelatedWork W1973842524 @default.
• W2003299841 hasRelatedWork W2009417959 @default.

• next